Ana içeriğe atla

Report: Covid-19 patients recovering quickly after getting experimental drug remdesivir

Report: Covid-19 Patients Recovering Quickly After Getting Experimental Drug Remdesivir


Covid-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a conversation about the trial.
The patients taking part in a clinical trial of the drug have all had severe respiratory symptoms and fever, but were able to leave the hospital after less than a week of treatment, STAT quoted the doctor leading the trial as saying.
"The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," Dr. Kathleen Mullane, an infectious disease specialist at the University of Chicago who is leading the clinical trial, said in the video.
Mullane did not immediately respond to a request for comment from CNN.
The University of Chicago said Mullane's comments constituted partial information.
"Partial data from an ongoing clinical trial is by definition incomplete and should never be used to draw conclusions about the safety or efficacy of a potential treatment that is under investigation," it said in a statement.
"In this case, information from an internal forum for research colleagues concerning work in progress was released without authorization. Drawing any conclusions at this point is premature and scientifically unsound."
There is no approved therapy for the Covid-19, which can cause severe pneumonia and acute respiratory distress syndrome in some patients. But the National Institutes of Health is organizing trials of several drugs and other treatments, among them remdesivir.
The drug, made by Gilead Sciences, was tested against Ebola with little success, but multiple studies in animals showed the drug could both prevent and treat coronaviruses related to Covid-19, including SARS (Severe Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome).
Back in February, the World Health Organization said remdesivir showed potential against Covid-19.
STAT said it obtained and viewed a copy of the video discussion Mullane had last week with colleagues about the trial.
"Most of our patients are severe and most of them are leaving at six days, so that tells us duration of therapy doesn't have to be 10 days," she was quoted as saying.
However, the trial does not include what's known as a control group, so it will be difficult to say whether the drug is truly helping patients recover better. With a control arm, some patients do not receive the drug being tested so that doctors can determine whether it's the drug that is really affecting their condition.
Trials of the drug are ongoing at dozens of other clinical centers, as well. Gilead is sponsoring tests of the drug in 2,400 patients with severe Covid-19 symptoms in 152 trial sites around the world. It's also testing the drug in 1,600 patients with moderate symptoms at 169 hospitals and clinics around the world.
Gilead said it expected results from the trial by the end of the month.
"We understand the urgent need for a COVID-19 treatment and the resulting interest in data on our investigational antiviral drug remdesivir," the company said in a statement to CNN. But it said a few stories about patients are just that -- stories.
"The totality of the data need to be analyzed in order to draw any conclusions from the trial. Anecdotal reports, while encouraging, do not provide the statistical power necessary to determine the safety and efficacy profile of remdesivir as a treatment for Covid-19," Gilead said.

Yorumlar

Yorum Gönder

Bu blogdaki popüler yayınlar

Migrant Workers Sprayed With Disinfectant In One Indian State

Migrant Workers Sprayed With Disinfectant In One Indian State New Delhi (CNN) The Indian state of Uttar Pradesh has sparked controversy after migrant workers, returning home during a nationwide coronavirus lockdown, were doused in bleach disinfectant used to sanitize buses. Video showed three people, dressed in protective gear, spraying the liquid directly on a group of Indian workers as they sat on the ground in the northern city of Bareilly. Social distancing is a privilege of the middle class. For India's slum dwellers, it will be impossible Ashok Gautam, a senior officer in charge of Covid-19 operations in Uttar Pradesh, told CNN as many as 5,000 people have been "publicly sprayed" when they arrived before they were allowed to disperse. "We sprayed them here as part of the disinfection drive, we don't want them to be carriers for the virus and it could be hanging on their clothes, now all borders have been sealed so this won't h...
Yorum Gönder
Devamı

Why COVID-19 makes a compelling case for the wider integration of blockchain

Why COVID-19 Makes A Compelling Case For The Wider İntegration Of Blockchain The COVID-19 crisis has revealed a general lack of connectivity and data exchange built into our global supply chains. Future resiliency will depend on building transparent, inter-operable and connective networks. When it became clear that many of us would soon be working from home, a majority took a cursory glance at their home office set-ups and decided it needed upgrading. What ensued was an unanticipated rush and surge of online orders for office desks, chairs, lamps and computer hardware. But such was the sudden spike that it has unsurprisingly caught suppliers large and small unprepared, off guard and exposed gaping holes in their ability to track purchases from one end of their supply chains to the other. Some customers, who have spent no small amount on revamping their home offices are still waiting to do so, without the consolation of being able to see where their orders are, or when they...
Yorum Gönder
Devamı

What the COVID-19 pandemic tells us about gender equality

What the COVID-19 Pandemic Tells us About Gender Equality Women make up 70% of all health and social-services staff globally. Domestic, sexual and gender-based violence increases during crises. Women earn just 79 cents for every dollar men make. Given that the COVID-19 crisis affects men and women in different ways, measures to resolve it must take gender into account. For women and girls, vulnerabilities in the home, on the front lines of health care, and in the labor market must be addressed. Regardless of where one looks, it is women who bear most of the responsibility for holding societies together, be it at home, in health care, at school, or in caring for the elderly. In many countries, women perform these tasks without pay. Yet even when the work is carried out by professionals, those professions tend to be dominated by women, and they tend to pay less than male-dominated professions. The COVID-19 crisis has thrown these gender-based differences into ...
Yorum Gönder
Devamı